Literature DB >> 34549979

Multiplexed Simian Immunodeficiency Virus-Specific Paired RNA-Guided Cas9 Nickases Inactivate Proviral DNA.

Lisa M Smith1,2, Jason T Ladner3, Vida L Hodara1, Laura M Parodi1, R Alan Harris4,5, Jessica E Callery1, Zhao Lai6,7, Yi Zou7, Muthuswamy Raveedran4,5, Jeffrey Rogers4,5, Luis D Giavedoni1.   

Abstract

Human and simian immunodeficiency virus (HIV and SIV) infections establish lifelong reservoirs of cells harboring an integrated proviral genome. Genome editing CRISPR-associated Cas9 nucleases, combined with SIV-specific guiding RNA (gRNA) molecules, inactivate integrated provirus DNA in vitro and in animal models. We generated RNA-guided Cas9 nucleases (RGNu) and nickases (RGNi) targeting conserved SIV regions with no homology in the human or rhesus macaque genome. Assays in cells cotransfected with SIV provirus and plasmids coding for RGNus identified SIV long terminal repeat (LTR), trans-activation response (TAR) element, and ribosome slip site (RSS) regions as the most effective at virus suppression; RGNi targeting these regions inhibited virus production significantly. Multiplex plasmids that coexpressed these three RGNu (Nu3), or six (three pairs) RGNi (Ni6), were more efficient at virus suppression than any combination of individual RGNu and RGNi plasmids. Both Nu3 and Ni6 plasmids were tested in lymphoid cells chronically infected with SIVmac239, and whole-genome sequencing was used to determine on- and off-target mutations. Treatment with these all-in-one plasmids resulted in similar levels of mutations of viral sequences from the cellular genome; Nu3 induced indels at the 3 SIV-specific sites, whereas for Ni6 indels were present at the LTR and TAR sites. Levels of off-target effects detected by two different algorithms were indistinguishable from background mutations. In summary, we demonstrate that Cas9 nickase in association with gRNA pairs can specifically eliminate parts of the integrated provirus DNA; also, we show that careful design of an all-in-one plasmid coding for 3 gRNAs and Cas9 nuclease inhibits SIV production with undetectable off-target mutations, making these tools a desirable prospect for moving into animal studies. IMPORTANCE Our approach to HIV cure, utilizing the translatable SIV/rhesus macaque model system, aims at provirus inactivation and its removal with the least possible off-target side effects. We developed single molecules that delivered either three truncated SIV-specific gRNAs along with Cas9 nuclease or three pairs of SIV-specific gRNAs (six individual gRNAs) along with Cas9 nickase to enhance efficacy of on-target mutagenesis. Whole-genome sequencing demonstrated effective SIV sequence mutation and inactivation and the absence of demonstrable off-target mutations. These results open the possibility to employ Cas9 variants that introduce single-strand DNA breaks to eliminate integrated proviral DNA.

Entities:  

Keywords:  CRISPR/Cas9; SIV; genome editing; nickase; off-target mutation

Mesh:

Substances:

Year:  2021        PMID: 34549979      PMCID: PMC8577357          DOI: 10.1128/JVI.00882-21

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  65 in total

Review 1.  Animal models for the study of human immunodeficiency virus infections.

Authors:  N L Letvin
Journal:  Curr Opin Immunol       Date:  1992-08       Impact factor: 7.486

2.  Nucleosomes Inhibit Cas9 Endonuclease Activity in Vitro.

Authors:  John M Hinz; Marian F Laughery; John J Wyrick
Journal:  Biochemistry       Date:  2015-11-24       Impact factor: 3.162

3.  An engineered lox sequence containing part of a long terminal repeat of HIV-1 permits Cre recombinase-mediated DNA excision.

Authors:  Y S Lee; S T Kim; G W Kim; M Lee; J S Park
Journal:  Biochem Cell Biol       Date:  2000       Impact factor: 3.626

4.  Low incidence of off-target mutations in individual CRISPR-Cas9 and TALEN targeted human stem cell clones detected by whole-genome sequencing.

Authors:  Adrian Veres; Bridget S Gosis; Qiurong Ding; Ryan Collins; Ashok Ragavendran; Harrison Brand; Serkan Erdin; Chad A Cowan; Michael E Talkowski; Kiran Musunuru
Journal:  Cell Stem Cell       Date:  2014-07-03       Impact factor: 24.633

5.  Isolation of T-cell tropic HTLV-III-like retrovirus from macaques.

Authors:  M D Daniel; N L Letvin; N W King; M Kannagi; P K Sehgal; R D Hunt; P J Kanki; M Essex; R C Desrosiers
Journal:  Science       Date:  1985-06-07       Impact factor: 47.728

6.  CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering.

Authors:  Prashant Mali; John Aach; P Benjamin Stranges; Kevin M Esvelt; Mark Moosburner; Sriram Kosuri; Luhan Yang; George M Church
Journal:  Nat Biotechnol       Date:  2013-08-01       Impact factor: 54.908

7.  DELLY: structural variant discovery by integrated paired-end and split-read analysis.

Authors:  Tobias Rausch; Thomas Zichner; Andreas Schlattl; Adrian M Stütz; Vladimir Benes; Jan O Korbel
Journal:  Bioinformatics       Date:  2012-09-15       Impact factor: 6.937

8.  An efficient low cost method for gene transfer to T lymphocytes.

Authors:  Leonardo Chicaybam; Andressa Laino Sodre; Bianca Azevedo Curzio; Martin Hernan Bonamino
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

9.  Improving CRISPR-Cas nuclease specificity using truncated guide RNAs.

Authors:  Yanfang Fu; Jeffry D Sander; Deepak Reyon; Vincent M Cascio; J Keith Joung
Journal:  Nat Biotechnol       Date:  2014-01-26       Impact factor: 54.908

10.  CRISPR based editing of SIV proviral DNA in ART treated non-human primates.

Authors:  Pietro Mancuso; Chen Chen; Rafal Kaminski; Jennifer Gordon; Shuren Liao; Jake A Robinson; Mandy D Smith; Hong Liu; Ilker K Sariyer; Rahsan Sariyer; Tiffany A Peterson; Martina Donadoni; Jaclyn B Williams; Summer Siddiqui; Bruce A Bunnell; Binhua Ling; Andrew G MacLean; Tricia H Burdo; Kamel Khalili
Journal:  Nat Commun       Date:  2020-11-27       Impact factor: 17.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.